NVSEF
NOVARTIS AG BASEL AKT
stockOTC
novartis provides healthcare solutions that improve and extend people's lives. we use science-based innovation to address some of society's most challenging healthcare issues. we discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. our company is focused on industry-leading divisions with innovation power and global scale: pharmaceuticals, eye care and generic medicines novartis is headquartered in basel, switzerland. novartis group companies employ approximately 120,000 associates and its products are available in more than 180 countries around the world. see our community guidelines: https://www.novartis.com/sites/www.novartis.com/files/linkedin-community-guidelines.pdf
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 146.00 | 2026-09-28 | -8.08% | -4.230 |
| 1M | 164.25 | 2026-09-03 | -18.30% | 2.143 |
| 3M | 158.24 | 2026-07-02 | -15.19% | 1.266 |
| 6M | 154.88 | 2026-04-01 | -13.35% | 0.661 |
| 1Y | 127.96 | 2025-10-03 | +4.88% | 0.276 |
| 2Y | 109.70 | 2024-10-03 | +22.33% | — |
| 5Y | 83.00 | 2021-10-04 | +61.69% | -0.057 |
NOVARTIS AG BASEL AKT (OTC:NVSEF) stock price today is $134.20, and today's volume is 633. NVSEF is down 4.775% today. The 30 day average volume is 26,007. NVSEF market cap is $293.89B with 2.19B shares outstanding.